These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10724656)

  • 1. Notified body consensus statements.
    Donawa M
    Med Device Technol; 1999 Nov; 10(9):46-9, 51. PubMed ID: 10724656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notified body recommendations.
    Donawa M
    Med Device Technol; 2000 May; 11(4):37-40. PubMed ID: 11010318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notified Body guidance on clinical evaluation.
    Donawa M
    Med Device Technol; 2000 Sep; 11(7):26-8. PubMed ID: 15326742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using and controlling subcontractors.
    Burton W
    Med Device Technol; 1997 Dec; 8(10):14-6. PubMed ID: 10176362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The responsibilities of importers and distributors.
    Donawa ME
    Med Device Technol; 1998 Sep; 9(7):12-4, 16-8. PubMed ID: 10186979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European and US quality system requirements for packaging.
    Donawa ME
    Med Device Technol; 1997 May; 8(4):12-4, 16-7. PubMed ID: 10167684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controls on clinical investigations in Europe: national differences.
    Sorrel S
    Med Device Technol; 1997 May; 8(4):22-6. PubMed ID: 10173028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EC declaration of conformity.
    Donawa ME
    Med Device Technol; 1996 May; 7(4):10-2. PubMed ID: 10163370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notified bodies. Questions and answers.
    Lindley E
    Med Device Technol; 1995 Mar; 6(2):38-43. PubMed ID: 10155376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the new quality management system standards on the CE-marking process.
    Donawa M
    Med Device Technol; 2001; 12(1):34-9. PubMed ID: 11317864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of being authorized.
    Donawa ME
    Med Device Technol; 1996 Apr; 7(3):11-3. PubMed ID: 10163367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proposed in vitro diagnostic directive.
    Donawa ME
    Med Device Technol; 1995 Sep; 6(7):12-6. PubMed ID: 10155394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk analysis: a standard approach? (Part II).
    Donawa ME
    Med Device Technol; 1995 May; 6(4):10-2. PubMed ID: 10155382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the notified body in the CE marking of medical devices.
    Rader J; Schaff P; Kreinberg W
    Health Estate; 1999 Apr; 53(3):14-6. PubMed ID: 10387568
    [No Abstract]   [Full Text] [Related]  

  • 15. The European regulation of drug-delivery devices.
    Donawa ME
    Med Device Technol; 1996 Oct; 7(8):12-6. PubMed ID: 10163669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality planning conundrum.
    Donawa ME
    Med Device Technol; 1999; 10(6):14-6. PubMed ID: 10623345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed amendments to the medical devices Directives.
    Donawa M
    Med Device Technol; 2006; 17(1):22-5. PubMed ID: 16483107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Animal Tissue Directive.
    Donawa M
    Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Focus Notified Bodies. New requirements for designation and monitoring].
    Poos U; Edelhäuser R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1362-7. PubMed ID: 25373553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk analysis: a standard approach? (Part I).
    Donawa ME
    Med Device Technol; 1995 Apr; 6(3):11-4. PubMed ID: 10172443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.